Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Capecitabine in the Perioperative Treatment of Rectal Cancer (Rektum-III)

This study has been completed.
Information provided by (Responsible Party):
Frederik Wenz, University Hospital Mannheim Identifier:
First received: December 21, 2011
Last updated: December 26, 2011
Last verified: December 2011